Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GURUSHER PANJRATH

Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology

NPI
1437325883
CMS profile
156247
Location
WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$139,157.50

139 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 3 of 3; records 101–139 of 139 matching records. This page contains 39 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GURUSHER PANJRATH

NPI 1437325883 · CMS profile ID 156247

Allopathic & Osteopathic Physicians / Internal Medicine / Advanced Heart Failure and Transplant Cardiology

WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–139 of 139 matching records. This page contains 39 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1437325883?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GURUSHER PANJRATH, NPI 1437325883, CMS profile ID 156247. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–139 of 139 matching records. This page contains 39 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1437325883?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). GURUSHER PANJRATH, NPI 1437325883, CMS profile ID 156247. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–139 of 139 matching records. This page contains 39 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1437325883?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
GURUSHER PANJRATH, NPI 1437325883, CMS profile ID 156247, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–139 of 139 matching records. This page contains 39 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1437325883?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

139 matching records · $139,157.50 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 139 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–139 of 139.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Alnylam Pharmaceuticals Inc. $50.0004/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212764624 CMS
Alnylam Pharmaceuticals Inc. $49.9904/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212764626 CMS
Alnylam Pharmaceuticals Inc. $75.0004/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212764628 CMS
Alnylam Pharmaceuticals Inc. $49.9904/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212764630 CMS
Alnylam Pharmaceuticals Inc. $64.1304/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212764656 CMS
Alnylam Pharmaceuticals Inc. $712.9704/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212764614 CMS
Alnylam Pharmaceuticals Inc. $243.3904/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212764616 CMS
Alnylam Pharmaceuticals Inc. $49.9904/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212764620 CMS
Alnylam Pharmaceuticals Inc. $124.8404/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212764622 CMS
PFIZER INC. $119.7604/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230071198 CMS
CVRx, Inc. $396.4204/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1186332675 CMS
CVRx, Inc. $5,500.0004/17/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1186332677 CMS
E.R. Squibb & Sons, L.L.C. $16.0604/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184819087 CMS
CVRx, Inc. $4,000.0004/03/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1186332673 CMS
CVRx, Inc. $175.9303/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219175586 CMS
ABIOMED $144.6303/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174501951 CMS
Boston Scientific Corporation $117.2803/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181222324 CMS
CVRx, Inc. $195.0503/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218117899 CMS
CVRx, Inc. $266.2703/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1218117904 CMS
CVRx, Inc. $148.8103/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219175584 CMS
CVRx, Inc. $29.0803/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218117137 CMS
CVRx, Inc. $71.3003/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218117064 CMS
CVRx, Inc. $35.4003/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219175582 CMS
SCPHARMACEUTICALS INC. $21.6303/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228178164 CMS
CVRx, Inc. $150.7603/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218116355 CMS
CVRx, Inc. $253.2803/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218116358 CMS
CVRx, Inc. $366.9802/24/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1218115216 CMS
Alnylam Pharmaceuticals Inc. $148.9102/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212764640 CMS
CVRx, Inc. $1,000.0002/13/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1186332667 CMS
CVRx, Inc. $6,000.0002/13/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1186332669 CMS
CVRx, Inc. $20.9502/13/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1186332671 CMS
CVRx, Inc. $21.7702/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219175580 CMS
CVRx, Inc. $128.5902/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219175578 CMS
CVRx, Inc. $177.5701/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219175576 CMS
Abbott Laboratories $17.5501/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240598370 CMS
CVRx, Inc. $176.0101/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218110031 CMS
CVRx, Inc. $167.9201/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219175574 CMS
Medtronic, Inc. $45.9401/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218881140 CMS
CVRx, Inc. $1,000.0001/02/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1186332665 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $16,619.16 63
PY2020 $29,917.53 44
PY2021 $20,653.52 38
PY2022 $59,170.14 55
PY2023 $78,313.78 76
PY2024 $81,745.12 95
PY2025 $139,157.50 139

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $338,852.26 19
PY2024 Principal investigator $14,805.00 6
PY2023 Principal investigator $5,915.00 6
PY2022 Principal investigator $14,684.80 8
PY2021 Principal investigator $5,505.00 4
PY2020 Principal investigator $2,663.61 5
PY2019 Recipient $750.50 1
PY2019 Principal investigator $33,776.18 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

19 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $270,179.19 12/31/2025 Non-covered Recipient Entity
The George Washington University Medical Faculty Associates
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-PH due to Heart Failure with Preserved Ejection F No dispute reported 06/30/2026 1232938420
Principal investigator 1 CVRx, Inc. $702.00 12/23/2025 Non-covered Recipient Entity
Medical Faculty Associates, Inc
Not supplied No dispute reported 06/30/2026 1228698590
Principal investigator 1 Ionis Pharmaceuticals, Inc. $2,340.00 12/22/2025 Non-covered Recipient Entity
MEDICAL FACULTY ASSOCIATES INC
A PHASE 3 GLOBAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ION682884 IN PATIENTS WITH TRANSTHYRETINMEDIATED AMYLOID CARDIOMYOPATHY ATTRCM No dispute reported 06/30/2026 1246791679
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,064.70 10/31/2025 Non-covered Recipient Entity
MEDICAL FACULTY ASSOCIATES INC
A PHASE 3 GLOBAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ION682884 IN PATIENTS WITH TRANSTHYRETINMEDIATED AMYLOID CARDIOMYOPATHY ATTRCM No dispute reported 06/30/2026 1246789951
Principal investigator 1 CVRx, Inc. $1,195.00 10/28/2025 Non-covered Recipient Entity
Medical Faculty Associates, Inc
Not supplied No dispute reported 06/30/2026 1228698592
Principal investigator 1 Ionis Pharmaceuticals, Inc. $7,023.99 10/24/2025 Non-covered Recipient Entity
MEDICAL FACULTY ASSOCIATES INC
AN OPENLABEL EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY OF EPLONTERSEN ION682884 IN PATIENTS WITH TRANSTHYRETINMEDIATED AMYLOID CARDIOMYOPATHY ATTRCM No dispute reported 06/30/2026 1246789609
Principal investigator 1 Ionis Pharmaceuticals, Inc. $3,652.04 10/03/2025 Non-covered Recipient Entity
MEDICAL FACULTY ASSOCIATES INC
AN OPENLABEL EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY OF EPLONTERSEN ION682884 IN PATIENTS WITH TRANSTHYRETINMEDIATED AMYLOID CARDIOMYOPATHY ATTRCM No dispute reported 06/30/2026 1246787943
Principal investigator 1 Ionis Pharmaceuticals, Inc. $4,711.59 10/02/2025 Non-covered Recipient Entity
MEDICAL FACULTY ASSOCIATES INC
A PHASE 3 GLOBAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ION682884 IN PATIENTS WITH TRANSTHYRETINMEDIATED AMYLOID CARDIOMYOPATHY ATTRCM No dispute reported 06/30/2026 1246787790
Principal investigator 1 Ionis Pharmaceuticals, Inc. $3,966.30 09/01/2025 Non-covered Recipient Entity
MEDICAL FACULTY ASSOCIATES INC
A PHASE 3 GLOBAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ION682884 IN PATIENTS WITH TRANSTHYRETINMEDIATED AMYLOID CARDIOMYOPATHY ATTRCM No dispute reported 06/30/2026 1246787072
Principal investigator 1 Ionis Pharmaceuticals, Inc. $4,466.00 08/20/2025 Non-covered Recipient Entity
MEDICAL FACULTY ASSOCIATES INC
AN OPENLABEL EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY OF EPLONTERSEN ION682884 IN PATIENTS WITH TRANSTHYRETINMEDIATED AMYLOID CARDIOMYOPATHY ATTRCM No dispute reported 06/30/2026 1246786696
Principal investigator 1 Ionis Pharmaceuticals, Inc. $12,987.00 08/01/2025 Non-covered Recipient Entity
MEDICAL FACULTY ASSOCIATES INC
A PHASE 3 GLOBAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ION682884 IN PATIENTS WITH TRANSTHYRETINMEDIATED AMYLOID CARDIOMYOPATHY ATTRCM No dispute reported 06/30/2026 1246785934
Principal investigator 1 CVRx, Inc. $6,198.00 07/28/2025 Non-covered Recipient Entity
Medical Faculty Associates, Inc
Not supplied No dispute reported 06/30/2026 1228698598
Principal investigator 1 Ionis Pharmaceuticals, Inc. $2,889.90 07/28/2025 Non-covered Recipient Entity
MEDICAL FACULTY ASSOCIATES INC
A PHASE 3 GLOBAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ION682884 IN PATIENTS WITH TRANSTHYRETINMEDIATED AMYLOID CARDIOMYOPATHY ATTRCM No dispute reported 06/30/2026 1246785796
Principal investigator 1 Ionis Pharmaceuticals, Inc. $3,490.45 07/28/2025 Non-covered Recipient Entity
MEDICAL FACULTY ASSOCIATES INC
AN OPENLABEL EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY OF EPLONTERSEN ION682884 IN PATIENTS WITH TRANSTHYRETINMEDIATED AMYLOID CARDIOMYOPATHY ATTRCM No dispute reported 06/30/2026 1246785799
Principal investigator 1 CVRx, Inc. $400.00 07/02/2025 Non-covered Recipient Entity
Medical Faculty Associates, Inc
Not supplied No dispute reported 06/30/2026 1228698588
Principal investigator 1 Ionis Pharmaceuticals, Inc. $4,726.80 07/01/2025 Non-covered Recipient Entity
MEDICAL FACULTY ASSOCIATES INC
A PHASE 3 GLOBAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ION682884 IN PATIENTS WITH TRANSTHYRETINMEDIATED AMYLOID CARDIOMYOPATHY ATTRCM No dispute reported 06/30/2026 1246784882
Principal investigator 1 CVRx, Inc. $2,193.00 04/08/2025 Non-covered Recipient Entity
Medical Faculty Associates, Inc
Not supplied No dispute reported 06/30/2026 1228698594
Principal investigator 1 CVRx, Inc. $2,153.30 04/03/2025 Non-covered Recipient Entity
WCG IRB
Not supplied No dispute reported 06/30/2026 1228698838
Principal investigator 1 CVRx, Inc. $4,513.00 01/23/2025 Non-covered Recipient Entity
Medical Faculty Associates, Inc
Not supplied No dispute reported 06/30/2026 1228698596